Brendan Stats – CEO – TMK Energy Limited (ASX:TMK) is a gas exploration company listed on the Australian Stock Exchange. TMK holds a 67% interest in the Gurvantes XXXV Project located in the South Gobi Basin of Mongolia and also holds a 20% interest in the Talisman Depp Project containing the Napoleon Structure located in the Barrow-Dampier Sub-basin.
Copyright 2023 – Finance News Network
20 Jul 2020 - BluGlass Limited (ASX:BLG) Managing Director and CEO Giles Bourne gives an update on the commissioning of the BLG 500 at Silverwater, strategic alliances and product roadmap.
31 Aug 2020 - Sequoia Financial Group Limited (ASX:SEQ) Managing Director & CEO Garry Crole talks about the company's group strategy, outlook, and much improved FY20 results, despite the challenging operating environment.
28 Sep 2022 - Meeka Metals Limited (ASX:MEK) Managing Director and CEO Tim Davidson discusses recent gold and rare earths results and the outlook for the next year.
27 Aug 2020 - IVE Group Limited (ASX:IGL) Executive Chairman Geoff Selig talks about FY20 results, the impact of COVID-19 on clients' marketing spend, group strategy and outlook.
03 Oct 2023 - Alex Hanly, CEO of Lithium Universe Limited (ASX:LU7), provides an update on the company's projects, discussing progress towards developing the Quebec Lithium Processing Hub.
24 Nov 2020 - SUDA Pharmaceuticals Limited (ASX:SUD) Managing Director Dr Michael Baker discusses the company's technology to convert solid dose drugs into oral sprays and the outlook for the year ahead.
10 Oct 2023 - Jon Price - Managing Director - Richmond Vanadium Technology (ASX:RVT) is an Australian minerals development company which is advancing the Richmond – Julia Creek Vanadium Project in Queensland through a Bankable Feasibility Study.
26 Aug 2021 - Chimeric Therapeutics Limited (ASX:CHM) Chief Operating Officer Jennifer Chow talks about the company's licensing of a novel, third-generation CDH17 CAR T cell therapy from the University of Pennsylvania, its recent FDA IND clearance and plans for ongoing growth.
29 Jul 2021 - BARD1 Life Sciences Limited (ASX:BD1) CEO Dr Leearne Hinch introduces the company, discussing its recent capital raising and share purchase plan.
